Delivery Order SPE2DR25D2104-SPE2DR26F3NRU
- Not listed
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $19,899.87 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg TimeSpan, a neurological medication used in military and veteran healthcare systems. This competitive award, issued on September 25, 2025, with completion targeted for September 26, 2025, represents a firm fixed-price delivery order with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $5,071.88 to AmerisourceBergen Drug Corp for Mestinon 180 mg Timespan in 30-tablet units. This contract, awarded on June 4, 2025, with completion targeted for June 5, 2025, represents a firm fixed-price delivery order with no set-aside designation. The award was competitively issued and performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $2,569.50 delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of Mestinon 180 mg Timespan in units of 30, with completion scheduled for September 24, 2025. This firm fixed-price contract represents a non-set-aside competitive award issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will...
- The Defense Logistics Agency awarded a delivery order valued at $35,530.01 to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This firm fixed-price delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a direct procurement of pharmaceutical products to support military and federal healthcare operations. The contract was competitively awarded with no set-aside designation, leveraging...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units at a firm fixed price ceiling value of $1,208.55. This is a non-set-aside, competitively awarded contract with an ultimate completion date of November 6, 2025. The product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $7,037.30 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of August 14, 2025. The contract is performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $3,382.75 delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the prime contractor. Performance will be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of November 4, 2025. This delivery order is issued under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $5,285.05 delivery order by the Defense Logistics Agency on June 18, 2025, for Mestinon 180 mg Timespan in quantities of 30. This firm fixed-price delivery order represents a non-competitive, non-set-aside award and is scheduled for completion by June 20, 2025. The contract fulfills pharmaceutical supply requirements for federal medical procurement, with performance taking...
- The Defense Logistics Agency awarded a $9,466.34 delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Mestinon 180 mg Timespan in quantities of 30 units. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. The product will be...
- The Defense Logistics Agency awarded a $9,986.88 delivery order to AmerisourceBergen Drug Corp for the supply of Mestinon 180 mg Timespan in quantities of 30 units. The contract, which carries a firm fixed price structure with no set-aside designation, was competitively awarded on September 27, 2025, with an ultimate completion date of September 29, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NRUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 7, 2025, for the supply of Mestinon 60 mg tablets (100-count units) under a firm fixed-price arrangement with a ceiling value of $6,998.47 and an ultimate completion date of November 10, 2025. This non-set-aside award represents a small-value transaction within AmerisourceBergen's extensive federal pharmaceutical supply portfolio. The place of performance is listed in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate headquarters is located. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen fulfills critical medical supply needs for military and veteran healthcare programs through competitively awarded contracts. The company's federal contract awards consistently demonstrate expertise in delivering a wide range of pharmaceutical products across multiple therapeutic domains, supporting organizations including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.0k | 11/7/25 |